Brain Sciences · 2019 · 36 citations · 35 references
MedicinePsychologyDementiaMemoryNeuropsychiatryCognitive AssessmentCognitive ImpairmentCognitive Impairment ManagementMemory AssessmentNeurocognitive AssessmentNeurocognitive DisordersCognitive Impairment AssociationsCognitive Impairment DetectionCognitive Impairment EvaluationHiv Antiretroviral TherapyHiv-associated Cognitive ImpairmentHiv-associated DementiaHuman Immunodeficiency Virus-associated NeuroimagingPatient Demographic Variables
As the HIV population ages, the prevalence of cognitive impairment (CI) is increasing, yet few services exist for the assessment and management of these individuals. Here we provide an initial description of a memory assessment service for people living with HIV and present data from a service evaluation undertaken in the clinic. We conducted an evaluation of the first 52 patients seen by the clinic. We present patient demographic data, assessment outcomes, diagnoses given and interventions delivered to those seen in the clinic. 41 patients (79%) of those seen in the clinic had objective CI: 16 (31%) met criteria for HIV-associated Neurocognitive Disorder (HAND), 2 (4%) were diagnosed with dementia, 14 (27%) showed CI associated with mental illness and/or drugs/alcohol, 7 (13%) had CI which was attributed to factors other than HIV and in 2 (4%) patients the cause remains unclear. 32 (62%) patients showed some abnormality on Magnetic Resonance Imaging (MRI) brain scans. Patients attending the clinic performed significantly worse than normative scores on all tests of global cognition and executive function. Interventions offered to patients included combination antiretroviral therapy modification, signposting to other services, case management, further health investigations and in-clinic advice. Our experience suggests that the need exists for specialist HIV memory services and that such a model of working can be successfully implemented into HIV patient care. Further work is needed on referral criteria and pathways. Diagnostic processes and treatment offered needs to consider and address the multifactorial aetiology of CI in HIV and this is essential for effective assessment and management.
35
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Michael Herdman, Claire Gudex, Andrew Lloyd et al. · Quality of Life Research · 2011 · 10K citations · Full text
Updated research nosology for HIV-associated neurocognitive disorders
Andrea Antinori, Gabriele Arendt, James T. Becker et al. · Neurology · 2007 · 2.6K citations
Medicine, Neurology, Neuroscience +14